DesertSci expands the marketing agreement with Infocom Corporation Tokyo, Japan
Desert Scientific Software Pty Ltd (Sydney, Australia) has extended the agreement with Infocom Corporation (Tokyo, Japan) to market all DesertSci's drug discovery software, including our innovative Scorpion and ViewContacts products, in the Japanese market.
The agreement between Desert Scientific Software and Infocom includes all DesertSci's proprietary chemoinformatics software: Proasis2, Proasis3, Spinifex, ViewContacts and Scorpion. DesertSci's products are well established among the top tier pharmaceutical companies in Europe and the US. This agreement provides an exciting opportunity for DesertSci to expand into a very important market and will help to build long term relationships within the growing Japanese pharmaceutical industry.
Infocom Corporation was established in February 1983. Infocom carries out wide-ranging business development centered on the areas of medical services, and drug discovery support and drug information, beginning with genomes with the keyword "drug". In the field of biosciences, in addressing the new "post-genome" era, Infocom aims to further strengthen their business foundation, including expanding solutions in the fields of proteomes and molecular design.
Infocom Corporation contact details for DesertSci's software products: Mr.Katsuo Kunugi, Chem & Bio Informatics Department, Product & Service Division, Sumitomo Fudosan Harajuku Bldg, 2-34-17, Jingumae, Shibuya-ku, Tokyo, 150-0001, Japan, e-mail : k.kunugi@infocom.co.jp.
Click here for more information on Proasis2
Click here for more information on Proasis3
Click here for more information on Scorpion